Comparison of factors associated with coronary artery dilation only versus coronary artery aneurysms in patients with Kawasaki disease
- PMID: 19962487
- DOI: 10.1016/j.amjcard.2009.07.062
Comparison of factors associated with coronary artery dilation only versus coronary artery aneurysms in patients with Kawasaki disease
Abstract
We sought to determine whether differences exist in the factors associated with transient coronary artery (CA) dilation only compared to CA aneurysms after Kawasaki disease (KD). We reviewed all patients with KD assessed and treated at a single tertiary institution from January 1990 to April 2007. Of 1,374 patients (63% men) with KD, 1,108 (81%) had no CA abnormalities; 180 (13%) had CA dilation only, and 86 (6%) had CA aneurysms. The factors associated with any CA abnormality included male gender (odds ratio [OR] 1.8, p <0.001), lower albumin (OR per 1 g/dl, 1.07; p < 0.001), lower hemoglobin (OR per 10 g/dl; 1.02, p = 0.008), diagnosed outside of the 1 to 9-year-age range (OR for <1 year old, 1.5; p = 0.04; OR for >9 years old, 1.9, p = 0.03), longer duration of fever before treatment (OR per day, 1.05, p = 0.002), greater platelet count (OR per 10 x 10(9)/L, 1.14, p = 0.008), and nonresponse to initial intravenous immunoglobulin treatment (OR 2.4, p <0.001). Only age at diagnosis, duration of fever before treatment, greater platelet count, and nonresponse to initial intravenous immunoglobulin discriminated between CA dilation only versus CA aneurysms (c-statistic, 0.80, p <0.001). In conclusion, CA dilation only and CA aneurysms differ only in the total duration of inflammation, as measured by the number of days from fever onset to defervescence.
Similar articles
-
Early treatment with intravenous immunoglobulin in patients with Kawasaki disease.J Pediatr. 2002 Apr;140(4):450-5. doi: 10.1067/mpd.2002.122469. J Pediatr. 2002. PMID: 12006960
-
Analysis of potential risk factors associated with nonresponse to initial intravenous immunoglobulin treatment among Kawasaki disease patients in Japan.Pediatr Infect Dis J. 2008 Feb;27(2):155-60. doi: 10.1097/INF.0b013e31815922b5. Pediatr Infect Dis J. 2008. PMID: 18174868
-
Treatment of acute Kawasaki disease: aspirin's role in the febrile stage revisited.Pediatrics. 2004 Dec;114(6):e689-93. doi: 10.1542/peds.2004-1037. Epub 2004 Nov 15. Pediatrics. 2004. PMID: 15545617
-
[Cardiovascular abnormalities in Kawasaki disease. An Italian prospective study].Cardiologia. 1998 Dec;43(12):1367-74. Cardiologia. 1998. PMID: 9988946 Italian.
-
Corticosteroid treatment of refractory Kawasaki disease.J Rheumatol. 2006 Apr;33(4):803-9. J Rheumatol. 2006. PMID: 16583481
Cited by
-
Development of a nomogram prediction model for early identification of persistent coronary artery aneurysms in kawasaki disease.BMC Pediatr. 2023 Feb 16;23(1):79. doi: 10.1186/s12887-023-03876-8. BMC Pediatr. 2023. PMID: 36797697 Free PMC article.
-
A machine learning model for distinguishing Kawasaki disease from sepsis.Sci Rep. 2023 Aug 2;13(1):12553. doi: 10.1038/s41598-023-39745-8. Sci Rep. 2023. PMID: 37532772 Free PMC article.
-
Biomarkers of intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease.World J Pediatr. 2019 Apr;15(2):168-175. doi: 10.1007/s12519-019-00234-6. Epub 2019 Feb 27. World J Pediatr. 2019. PMID: 30809758
-
Is there an association between intravenous immunoglobulin resistance and coronary artery lesion in Kawasaki disease?-Current evidence based on a meta-analysis.PLoS One. 2021 Mar 25;16(3):e0248812. doi: 10.1371/journal.pone.0248812. eCollection 2021. PLoS One. 2021. PMID: 33764989 Free PMC article.
-
Laboratory Markers in Incomplete Kawasaki Disease according to Coronary Artery Outcome.Korean Circ J. 2018 Apr;48(4):287-295. doi: 10.4070/kcj.2017.0342. Korean Circ J. 2018. PMID: 29625511 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous